Loading…
Product type
A Drug Master File (DMF) is a confidential document submitted to regulatory authorities that contains detailed information about the manufacturing, processing, and packaging of a drug substance or its intermediates. DMFs are primarily used to provide information to the FDA and other regulatory bodies to ensure compliance with safety and efficacy standards. They are essential for pharmaceutical companies to demonstrate the quality and reliability of their products.
| Content Type | Confidential technical information |
| Regulatory Authority | U.S. Food and Drug Administration (FDA) and other global agencies |
| Sections | Administrative, Chemistry, Manufacturing and Controls (CMC), and Safety |
| Submission Types | Type II DMF for drug substances and intermediates |
| Review Timeline | Typically ranges from 60 to 180 days |
When selecting a DMF, buyers should ensure that the file is up-to-date and compliant with the latest regulatory requirements. It is important to specify the type of DMF required (e.g., Type II for drug substances), as well as any particular sections that need to be included. Buyers should also inquire about the timeline for review and any associated fees. Understanding the specific needs of your product and its intended market is crucial for a successful DMF submission.
Get quotes for Dmf ( Drug Master File) Linked Products
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
A DMF provides detailed information about a drug substance to regulatory authorities to ensure compliance.
Manufacturers of drug substances or intermediates typically need to submit a DMF.
Review timelines can range from 60 to 180 days depending on the complexity.
Typical sections include Administrative, CMC, and Safety.
No, DMFs are confidential documents and are not publicly accessible.
Common types include Type I, Type II, and Type III, with Type II being for drug substances.